- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 515/08 - Systèmes pontés
Détention brevets de la classe C07D 515/08
Brevets de cette classe: 54
Historique des publications depuis 10 ans
|
5
|
3
|
1
|
2
|
3
|
5
|
13
|
3
|
6
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1579 |
13 |
| Atrin Pharmaceuticals LLC | 8 |
4 |
| Esperion Therapeutics, Inc. | 68 |
4 |
| Inflazome Limited | 84 |
3 |
| F. Hoffmann-La Roche AG | 7808 |
2 |
| Bayer Pharma AG | 1009 |
2 |
| The Board of Regents of the University of Texas System | 2303 |
2 |
| Aprea Therapeutics, Inc. | 8 |
2 |
| Isosterix, Inc. | 8 |
2 |
| Hoffmann-La Roche Inc. | 3818 |
1 |
| Merck Patent GmbH | 5735 |
1 |
| Massachusetts Institute of Technology | 10282 |
1 |
| The Brigham and Women's Hospital, Inc. | 2297 |
1 |
| The Broad Institute, Inc. | 1986 |
1 |
| Celgene Quanticel Research, Inc. | 154 |
1 |
| China Pharmaceutical University | 360 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1423 |
1 |
| Colorado State University Research Foundation | 722 |
1 |
| Istituto Nazionale di Genetica Molecolare-ingm | 24 |
1 |
| Ospedale San Raffaele S.r.l. | 315 |
1 |
| Autres propriétaires | 9 |